161 related articles for article (PubMed ID: 21523621)
1. The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.
Showalter TN; Zhan T; Anne PR; Chervoneva I; Mitchell EP; Yeo CJ; Rosato EL; Kennedy EP; Berger AC
J Gastrointest Surg; 2011 Aug; 15(8):1411-6. PubMed ID: 21523621
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
[TBL] [Abstract][Full Text] [Related]
3. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
[TBL] [Abstract][Full Text] [Related]
4. Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.
Colussi O; Voron T; Pozet A; Hammel P; Sauvanet A; Bachet JB; Vaillant JC; Rougier P; Nordlinger B; Berger A; Coriat R; Dousset B; Malka D; André T; Paye F; Aparicio T; Locher C; Cojean Zeleck D; Tchinou L; Bonnetain F; Taieb J
Eur J Surg Oncol; 2015 Apr; 41(4):520-6. PubMed ID: 25680954
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
Sakabe R; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakashima A; Ohge H; Sueda T; Hiyama E
Ann Surg Oncol; 2012 Sep; 19(9):3072-80. PubMed ID: 22322954
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.
Kawabata Y; Nishi T; Kidani A; Tajima Y
Pancreas; 2015 Aug; 44(6):937-44. PubMed ID: 25906447
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM
Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemo-radiotherapy in ampullary cancers.
Sikora SS; Balachandran P; Dimri K; Rastogi N; Kumar A; Saxena R; Kapoor VK
Eur J Surg Oncol; 2005 Mar; 31(2):158-63. PubMed ID: 15698732
[TBL] [Abstract][Full Text] [Related]
13. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
14. Is local resection adequate for T1 stage ampullary cancer?
Amini A; Miura JT; Jayakrishnan TT; Johnston FM; Tsai S; Christians KK; Gamblin TC; Turaga KK
HPB (Oxford); 2015 Jan; 17(1):66-71. PubMed ID: 25395092
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion is an independent prognostic factor in pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy with gemcitabine or S-1.
Aoyama T; Murakawa M; Katayama Y; Shiozawa M; Ueno M; Morimoto M; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Hepatogastroenterology; 2015; 62(138):472-7. PubMed ID: 25916085
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis.
Kamarajah SK
Clin Transl Oncol; 2018 Sep; 20(9):1212-1218. PubMed ID: 29497964
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
You DD; Lee HG; Heo JS; Choi SH; Choi DW
J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.
Demirci NS; Cavdar E; Ozdemir NY; Yuksel S; Iriagac Y; Erdem GU; Odabas H; Hacibekiroglu I; Karaagac M; Ucar M; Ozturk B; Bozkaya Y
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793001
[No Abstract] [Full Text] [Related]
20. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
Bhatia S; Miller RC; Haddock MG; Donohue JH; Krishnan S
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):514-9. PubMed ID: 16863684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
